Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Durai Sundar

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Plos One|February 4, 2012
Ashwagandha derived withanone targets TPX2-Aurora A complex: computational and experimental evidence to its anticancer activityAbhinav Grover, Rumani Singh, Ashutosh Shandilya, et al.
Marine Drugs|June 15, 2019
Marine Carotenoid Fucoxanthin Possesses Anti-Metastasis Activity: Molecular EvidenceSukant Garg, Sajal Afzal, Ahmed Elwakeel, et al.
Frontiers in Cell and Developmental Biology|September 29, 2022
Identification of a new member of Mortaparib class of inhibitors that target mortalin and PARP1Hazna Noor Meidinna, Seyad Shefrin, Anissa Nofita Sari, et al.
Journal of Biomolecular Structure & Dynamics|December 20, 2023
Molecular insights to the anti-COVID-19 potential of α-, β- and γ-cyclodextrinsVipul Kumar, Hazna Noor Meidinna, Sunil C Kaul, et al.
Journal of Biomolecular Structure & Dynamics|May 30, 2020
Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cellsVipul Kumar, Jaspreet Kaur Dhanjal, Priyanshu Bhargava, et al.
Current Topics in Medicinal Chemistry|January 27, 2024
Anti-COVID-19 Potential of Withaferin-A and Caffeic Acid Phenethyl EsterVipul Kumar, Anissa Nofita Sari, Dharmender Gupta, et al.
Cell Death & Disease|April 21, 2017
Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidencesYue Yu, Shashank P Katiyar, Durai Sundar, et al.
Plos One|September 17, 2015
Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer CellsNupur Nigam, Abhinav Grover, Sukriti Goyal, et al.
Viruses|December 23, 2022
Evolution of SARS-CoV-2: BA.4/BA.5 Variants Continues to Pose New ChallengesNeha Quadir, Jasdeep Singh, Anwar Alam, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 2, 2026
Molecular insights into the anti-COVID-19 activity of reduced (quinol) and oxidized (quinone) forms of coenzyme Q10Mangala Hegde, Vipul Kumar, Dharmender Gupta, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Plos One|February 4, 2012
Ashwagandha derived withanone targets TPX2-Aurora A complex: computational and experimental evidence to its anticancer activityAbhinav Grover, Rumani Singh, Ashutosh Shandilya, et al.
Marine Drugs|June 15, 2019
Marine Carotenoid Fucoxanthin Possesses Anti-Metastasis Activity: Molecular EvidenceSukant Garg, Sajal Afzal, Ahmed Elwakeel, et al.
Frontiers in Cell and Developmental Biology|September 29, 2022
Identification of a new member of Mortaparib class of inhibitors that target mortalin and PARP1Hazna Noor Meidinna, Seyad Shefrin, Anissa Nofita Sari, et al.
Journal of Biomolecular Structure & Dynamics|December 20, 2023
Molecular insights to the anti-COVID-19 potential of α-, β- and γ-cyclodextrinsVipul Kumar, Hazna Noor Meidinna, Sunil C Kaul, et al.
Journal of Biomolecular Structure & Dynamics|May 30, 2020
Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cellsVipul Kumar, Jaspreet Kaur Dhanjal, Priyanshu Bhargava, et al.
Current Topics in Medicinal Chemistry|January 27, 2024
Anti-COVID-19 Potential of Withaferin-A and Caffeic Acid Phenethyl EsterVipul Kumar, Anissa Nofita Sari, Dharmender Gupta, et al.
Cell Death & Disease|April 21, 2017
Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidencesYue Yu, Shashank P Katiyar, Durai Sundar, et al.
Plos One|September 17, 2015
Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer CellsNupur Nigam, Abhinav Grover, Sukriti Goyal, et al.
Viruses|December 23, 2022
Evolution of SARS-CoV-2: BA.4/BA.5 Variants Continues to Pose New ChallengesNeha Quadir, Jasdeep Singh, Anwar Alam, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 2, 2026
Molecular insights into the anti-COVID-19 activity of reduced (quinol) and oxidized (quinone) forms of coenzyme Q10Mangala Hegde, Vipul Kumar, Dharmender Gupta, et al.
Pageof 12